MRSN
Mersana Therapeutics
MRSN
MRSN
Delisted
MRSN was delisted on the 5th of January, 2026.
83 hedge funds and large institutions have $22.9M invested in Mersana Therapeutics in 2025 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 23 increasing their positions, 31 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
26% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 31
67% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 39
Holders
83
Holding in Top 10
–
Calls
$14K
Puts
$4K
Top Buyers
| 1 | +$735K | |
| 2 | +$707K | |
| 3 | +$365K | |
| 4 |
Goldman Sachs
New York
|
+$298K |
| 5 |
Two Sigma Investments
New York
|
+$271K |
Top Sellers
| 1 | -$1.6M | |
| 2 | -$1.23M | |
| 3 | -$756K | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$682K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$490K |